Evidence map›Paper›PMID 35920208›Full record

ArticleChembiochem : a European journal of chemical biology2022

Total Chemical Synthesis of a Functionalized GFP Nanobody.

Yara Huppelschoten, Angela F Elhebieshy, Dharjath S Hameed, Aysegul Sapmaz, Jens Buchardt, Thomas E Nielsen, Huib Ovaa, Gerbrand J van der Heden van Noort

Open access · hybridAbstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Total Chemical Synthesis of a Functionalized GFP Nanobody.Chembiochem : a European journal of chemical biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Yara HuppelschotenOncode Institute and Dept. Cell and Chemical Biology, Leiden University Medical Centre, Einthovenweg 2, 2333 ZC, Leiden, The Netherlands.
Angela F ElhebieshyOncode Institute and Dept. Cell and Chemical Biology, Leiden University Medical Centre, Einthovenweg 2, 2333 ZC, Leiden, The Netherlands.
Dharjath S HameedOncode Institute and Dept. Cell and Chemical Biology, Leiden University Medical Centre, Einthovenweg 2, 2333 ZC, Leiden, The Netherlands.
Aysegul SapmazOncode Institute and Dept. Cell and Chemical Biology, Leiden University Medical Centre, Einthovenweg 2, 2333 ZC, Leiden, The Netherlands.
Jens BuchardtGlobal Research Technologies, Novo Nordisk, Novo Nordisk Park, 2760, Måløv, Denmark.
Thomas E NielsenGlobal Research Technologies, Novo Nordisk, Novo Nordisk Park, 2760, Måløv, Denmark.
Huib OvaaOncode Institute and Dept. Cell and Chemical Biology, Leiden University Medical Centre, Einthovenweg 2, 2333 ZC, Leiden, The Netherlands.
Gerbrand J van der Heden van NoortOncode Institute and Dept. Cell and Chemical Biology, Leiden University Medical Centre, Einthovenweg 2, 2333 ZC, Leiden, The Netherlands.
Novo Nordisk (Denmark) · DKOncode Institute · NLLeiden University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemical protein synthesis has proven to be a powerful tool to access homogenously modified proteins. The chemical synthesis of nanobodies (Nb) would create possibilities to design tailored Nbs with a range of chemical modifications such as tags, linkers, reporter groups, and subsequently, Nb-drug conjugates. Herein, we describe the total chemical synthesis of a 123 amino-acid Nb against GFP. A native chemical ligation- desulfurization strategy was successfully applied for the synthesis of this GFP Nb, modified with a propargyl (PA) moiety for on-demand functionalization. Biophysical characterization indicated that the synthetic GFP Nb-PA was correctly folded after internal disulfide bond formation. The synthetic Nb-PA was functionalized with a biotin or a sulfo-cyanine5 dye by copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC), resulting in two distinct probes used for functional in vitro validation in pull-down and confocal microscopy settings.

Indexed as

AzidesSingle-Domain AntibodiesAlkynesBiotinClick ChemistryCopperDisulfidesProteinsAlkynesAzidesBiotinCopperDisulfidesProteinsSingle-Domain Antibodieschemical protein synthesisclick chemistrynanobodiesprotein modificationssolid phase peptide synthesis

Identifiers

PMID35920208
PMCPMC9804225
OpenAlexW4289544588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.